Maximilian Stahl, MD, assistant professor of medicine (medical oncology and hematology) and director of the leukemia and myeloid malignancy program at Yale Cancer Center, has received the DeLuca Center for Innovation in Hematology Career Development Award (CDA). The DeLuca Center for Innovation in Hematology Research at Smilow Cancer Hospital was formed thanks to a generous donation by the Fredrick A. DeLuca Foundation. The purpose of the CDA is to provide early career clinical or laboratory-based investigators in Hematology the opportunity to focus on research to advance patient care, therapies, and outcomes with the ultimate goal to achieve independent support for their research from a national agency.

Dr. Stahl cares for patients with hematologic malignancies with a particular focus on acute and chronic leukemias and myelodysplastic syndromes. His clinical research evaluates outcomes achieved with novel therapeutic approaches for AML, MDS, and MPNs, with a focus on identifying molecular predictors of these outcomes. Dr. Stahl actively leads clinical and translational research with the goal of bringing basic scientific discoveries from the lab to the clinic to benefit patients with leukemia. Towards this goal, he conducts early phase clinical trials testing novel treatment approaches.